График iShares Neuroscience and Healthcare ETF
Простой график
Расширенный график
Основные параметры
| ISIN | US46436E3532 |
| Бета | 1.86 |
| Валюта | usd |
| Годовая доходность | 36.76 |
| Дата основания | Aug 24. 2022 |
| Див доходность | 0.03 |
| Индекс | NYSE FactSet Global Neuro Biopharma and MedTech Net Index - Benchmark TR Net |
| Количество компаний | 41 |
| Комиссия | 0.47 |
| Регион | Global |
| Сайт | cсылка |
| Средний P/E | -1.06 |
| Страна | USA |
| Страна ISO | US |
| Тип актива | Equity |
| Топ 10 эмитентов, % | 42.76 |
| Изменение за день | -0.54% 30.98 $ |
| Изменение за неделю | -5% 32.43 $ |
| Изменение за месяц | -7.67% 33.37 $ |
| Изменение за 3 месяца | -2.95% 31.75 $ |
| Изменение за полгода | +23.23% 25 $ |
| Изменение за год | +21.59% 25.34 $ |
| Изменение с начала года | -4.96% 32.42 $ |
Оплатите подписку
Больше функциональности и данных для анализа компаний и портфеля доступно по подписке
Топ компаний
| Название | Отрасль | Доля, % | P/BV | P/S | P/E | EV/Ebitda | Дивидендная доходность | |
| #1 |
Praxis Precision Medicines, Inc. |
Healthcare | 5.3861 | 7.53 | 161.13 | -21.81 | -20.87 | 0 |
| #2 |
Axsome Therapeutics, Inc. |
Healthcare | 5.1109 | 71.25 | 10.53 | -17.55 | -14.45 | 0 |
| #3 |
Alkermes plc |
Healthcare | 4.7274 | 3.32 | 3.13 | 13.27 | 9.4 | 0 |
| #4 |
Biogen |
Healthcare | 4.558 | 1.31 | 2.26 | 13.43 | 9.25 | 0 |
| #5 |
Scholar Rock Holding Corporation |
Healthcare | 4.2988 | 19.04 | 13.88 | -12.37 | -13.45 | 0 |
| #6 |
Xenon Pharmaceuticals Inc. |
Healthcare | 3.8772 | 3.98 | 244.38 | -12.52 | -12.16 | 0 |
| #7 |
Supernus Pharmaceuticals, Inc. |
Healthcare | 3.8545 | 0.0027 | 3.92 | -73.08 | 1941.46 | 0 |
| #8 |
PTC Therapeutics, Inc. |
Healthcare | 3.7825 | -27.25 | 3.23 | 8.2 | 7 | 0 |
| #9 |
Catalyst Pharmaceuticals, Inc. |
Healthcare | 3.7546 | 3.1 | 5.02 | 13.79 | 7.34 | 0 |
| #10 |
Denali Therapeutics Inc. |
Healthcare | 3.4105 | 3.58 | 9.13 | -7.09 | -5.5 | 0 |
Похожие ETF
Описание iShares Neuroscience and Healthcare ETF
The fund will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents as well as in securities not included in the index, but which BFA believes will help the fund track the index. It is non-diversified.
На основе источников: porti.ru
MAX








